Japan’s National Cancer Center Hospital, the country’s preeminent hospital for cancer treatment, is active in the advancement of leading-edge cancer treatments, trains healthcare workers and, in conjunction with corporations and universities, conducts clinical research and trials for the development of next-generation treatment.
Patients from all across Japan with difficult-to-diagnose illnesses visit the National Cancer Center Hospital. Emphasizing patient welfare, the hospital chooses a diagnostic method suited to each person to attain the best possible test results in the shortest time. As diagnostic ultrasound systems are non-invasive and don’t expose patients to radiation, there is no need for concern over side effects. These indispensable devices are used at every stage from diagnosis to post-treatment convalescence.
Canon Medical Systems’ Aplio i-series is the main diagnostic ultrasound system used for examinations at the hospital. Doctors and technicians can select the ideal transducers and parameters for the body part or organ under examination in pursuit of impressive images that lead to more accurate diagnoses.
When developing diagnostic systems, Canon Medical undertakes joint research with various medical institutions, heeding their evaluations and advice in order to improve image quality. Today, the evolution of ultrasound image quality has even made possible the early detection of such diseases as pancreatic cancer, which is difficult to detect with CT and MRI. Canon Medical’s diagnostic systems are driving the early detection and accurate treatment of cancer to higher levels of precision.
Canon Medical, which joined the Group in 2016, has become the heart of Canon’s medical business. A pioneer of diagnostic imaging systems, the company has achieved numerous world’s-first and first-in-Japan solutions in such areas as CT scanners, MRI systems, ultrasound systems and X-ray angiography systems.
Under its Made for Life management philosophy, Canon Medical is accelerating the development of technology and the commercialization of products that contribute to human health and protect precious lives. The integration of Canon Medical’s technologies with Canon’s expertise in imaging and manufacturing has given rise to never-before-seen innovations.
Even before welcoming Canon Medical to the Group, Canon had made important contributions to healthcare with advances in digital radiography and ophthalmic equipment. Moving forward together, Canon and Canon Medical will continue to collaborate with medical institutions, corporations and universities worldwide and undertake the challenge of developing advanced technologies in new fields.
Canon Medical Systems aims to provide efficient patient-centric solutions in the three fields of diagnostic imaging, medical IT and in-vitro diagnostics.
In the field of diagnostic imaging, we are undertaking open innovation with leading medical institutes and universities worldwide to produce higher-resolution images that will contribute to greater diagnostic precision. At the same time, we are developing technologies that will reduce the burden on patients through lower radiation doses and shorter exam times.
With an eye toward optimizing healthcare, we are implementing such leading-edge technologies as AI in the field of medical IT for the collection, consolidation, analysis and processing of medical information to provide medical professionals with more cogent data.
Lastly, in the field of in-vitro diagnostics, we are working to develop such solutions as blood and gene testing, DNA chips and rapid gene testing towards earlier disease detection and preventing the spread of infections.